Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Duan, Wei  [Clear All Filters]
2023
Wei M, Nurjanah U, Li J, Luo X, Hosea R, Li Y, Zeng J, Duan W, Song G, Miyagishi M, et al. YY2-DRP1 Axis Regulates Mitochondrial Fission and Determines Cancer Stem Cell Asymmetric Division. Adv Sci (Weinh). 2023:e2207349.
2021
Moitra P, Misra SK, Kumar K, Kondaiah P, Tran P, Duan W, Bhattacharya S. Cancer Stem Cell-Targeted Gene Delivery Mediated by Aptamer-Decorated pH-Sensitive Nanoliposomes. ACS Biomater Sci Eng. 2021.
2020
Zhou G, Bae SDa Won, Nguyen R, Huo X, Han S, Zhang Z, Hebbard L, Duan W, Eslam M, Liddle C, et al. An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells. Cancer Lett. 2020.
2016
Deng J, Wang L, Chen H, Hao J, Ni J, Chang L, Duan W, Graham P, Li Y. Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer. Oncotarget. 2016.
2015
Wang Y-Y, Yang Y-X, Zhao R, Pan S-T, Zhe H, He Z-X, Duan W, Zhang X, Yang T, Qiu J-X, et al. Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells. Drug Des Devel Ther. 2015;9:993-1026.
Wang T, Gantier MP, Xiang D, Bean AG, Bruce M, Zhou S-F, Khasraw M, Ward A, Wang L, Wei MQ, et al. EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model. Theranostics. 2015;5(12):1456-72.
Xiang D, Shigdar S, Qiao G, Wang T, Kouzani AZ, Zhou S-F, Kong L, Li Y, Pu C, Duan W. Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine. Theranostics. 2015;5(1):23-42.
Li J-P, Yang Y-X, Liu Q-L, Zhou Z-W, Pan S-T, He Z-X, Zhang X, Yang T, Pan S-Y, Duan W, et al. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells. Drug Des Devel Ther. 2015;9:1027-62.
Chen X-W, He Z-X, Zhou Z-W, Yang T, Zhang X, Yang Y-X, Duan W, Zhou S-F. An update on the clinical pharmacology of the dipeptidyl peptidase 4 inhibitor alogliptin used for the treatment of type 2 diabetes mellitus. Clin Exp Pharmacol Physiol. 2015.
2014
Lin J, Shigdar S, Fang DZhi, Xiang D, Wei MQ, Danks A, Kong L, Li L, Qiao L, Duan W. Improved Efficacy and Reduced Toxicity of Doxorubicin Encapsulated in Sulfatide-Containing Nanoliposome in a Glioma Model. PLoS One. 2014;9(7):e103736.